UnitedHealth Group (NYSE: UNH) 在2024年第三季度财报电话会议上重申了全年盈利展望，尽管面临Medicare费率削减和Medicaid会员资格重新认定等挑战。公司报告了强劲增长，在商业产品中服务超过200万新消费者，并通过Optum Rx完成了16亿次处方配药。 UnitedHealth Group报告第三季度表现强劲，首席执行官Andrew Witty强调了公司的 ...

The company also trimmed the higher end of its 2024 adjusted profit forecast by 25 cents to $27.75 per share, partially due ...

UnitedHealth Group reported $6 billion in third quarter earnings that helped overcome costs of a cyberattack earlier this ...

Good morning, and welcome to the UnitedHealth Group's third-quarter 2024 earnings conference call. A question-and-answer ...

UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the ...

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated ...

Stocks were falling Tuesday as tumbling chip stocks sent the S&P 500 lower.These stocks were making moves Tuesday:ASML ...

UnitedHealth Group reported increased revenue, but also noted some cyberattack challenges that ended up affecting full-year ...

Key Takeaways Major U.S. indexes lost ground Tuesday after reaching record highs Monday as investors weighed the latest ...

Medical costs continue to surge more than expected for health insurers.

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

UnitedHealth Group is in a strong position this Medicare Advantage enrollment period as rivals scale back, CEO Andrew Witty ...